StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
198
This month
3
This year
24
Publishing Date
2024 - 04 - 11
2
2024 - 01 - 17
3
2024 - 01 - 16
2
2024 - 01 - 09
2
2023 - 12 - 01
2
2023 - 11 - 28
2
2023 - 11 - 09
2
2023 - 11 - 03
2
2023 - 10 - 04
2
2023 - 10 - 03
4
2023 - 09 - 18
2
2023 - 09 - 11
3
2023 - 08 - 25
2
2023 - 03 - 31
2
2023 - 03 - 16
3
2023 - 02 - 20
2
2023 - 02 - 17
4
2023 - 02 - 08
2
2022 - 10 - 14
2
2022 - 09 - 29
2
2022 - 09 - 19
2
2022 - 06 - 27
2
2022 - 03 - 25
4
2021 - 12 - 22
3
2021 - 12 - 20
2
2021 - 12 - 06
2
2021 - 11 - 10
1
2021 - 11 - 04
1
2021 - 11 - 01
1
2021 - 10 - 29
1
2021 - 10 - 25
1
2021 - 10 - 08
1
2021 - 09 - 22
1
2021 - 09 - 16
1
2021 - 09 - 08
1
2021 - 08 - 31
1
2021 - 08 - 27
1
2021 - 07 - 20
1
2021 - 07 - 16
1
2021 - 06 - 08
1
2021 - 06 - 03
1
2021 - 06 - 01
1
2021 - 05 - 27
1
2021 - 05 - 26
1
2021 - 05 - 24
1
2021 - 05 - 21
1
2021 - 05 - 07
1
2021 - 05 - 05
1
2021 - 05 - 04
1
2021 - 05 - 03
1
2021 - 05 - 01
1
2021 - 04 - 27
1
2021 - 04 - 12
1
2021 - 04 - 09
1
2021 - 04 - 07
1
2021 - 04 - 01
1
2021 - 03 - 29
1
2021 - 03 - 18
1
2021 - 03 - 08
1
2021 - 03 - 04
1
Sector
Commercial services
2
Consumer durables
1
Consumer non-durables
1
Electronic technology
7
Finance
1
Health care and social assistance
1
Health services
1
Health technology
198
Manufacturing
18
N/a
14
Process industries
3
Producer manufacturing
4
Professional, scientific, and technical services
1
Technology services
1
Tags
Agreement
5
Alzheimer's
3
America
36
Antibody
3
Application
5
Approval
12
Asia
4
Biocapital
3
Biosimilar
23
Cancer
16
Chmp
10
Collaboration
3
Commercialization
3
Cosentyx
3
Covid
4
Covid-19
3
Disease
14
Drug
10
Ema
6
Europe
4
Fabhalta
3
Fda
23
Fda approval
6
Financial
4
Financial results
3
For
3
Global
15
Grant
3
Granted
4
Growing
5
Growth
48
Health
3
Her2
3
Her2-
3
Immunotherapy
3
Injection
4
Jakavi
3
Kisqali
3
Leukemia
5
License
8
Market
73
Molecular
3
Myeloid leukemia
3
N/a
176
Novartis
30
Patent
5
Pipeline
3
Positive
13
Potential
3
Prostate cancer
3
Report
16
Research
7
Results
10
Sclerosis
6
Solutions
5
Study
4
Therapeutics
19
Therapy
17
Treatment
27
Trial
5
Entities
2seventy bio, inc.
1
3m company
2
Abbott laboratories
13
Abbvie inc.
39
Abeona therapeutics inc.
2
Acadia pharmaceuticals inc.
1
Acelyrin, inc.
1
Adaptimmune therapeutics plc
3
Adt inc.
1
Advantest corp
1
Agilent technologies, inc.
1
Agios pharmaceuticals, inc.
1
Albemarle corporation
1
Alcon inc.
6
Alkermes plc
1
Allakos inc.
1
Allovir, inc.
1
Alvotech lux holdings s.a.s.
4
Amgen inc.
25
Apple inc.
2
Astellas pharma inc
11
Astrazeneca plc
26
Bausch health companies inc.
6
Baxter international inc.
9
Becton, dickinson and company
3
Biogen inc.
9
Biontech se
3
Boston scientific corporation
2
Bristol-myers squibb company
2
Csl ltd
2
Denali therapeutics inc.
2
Eli lilly and company
11
Erasca inc
3
General electric company
3
Generation bio co.
2
Genmab a/s
8
Gilead sciences, inc.
2
Glaxosmithkline plc
40
Grifols sa
2
Immutep limited
3
Incyte corporation
5
Johnson & johnson
29
Kamada ltd.
4
Lantheus holdings, inc.
2
Mallinckrodt plc
3
Medtronic plc
3
Meiragtx holdings plc
2
Morphosys ag
2
Novartis ag
198
Novo nordisk a/s
6
Orchard therapeutics plc
2
Pfizer, inc.
5
Sanofi
41
Seagen inc.
3
Takeda pharmaceutical company limited
3
Teva pharmaceutical industries ltd
36
Thermo fisher scientific inc
8
United therapeutics corporation
2
Viatris inc.
20
Voyager therapeutics, inc.
2
Symbols
AAPL
192
ABB
220
ABBV
235
ABLZF
207
ABT
287
AMGN
116
ARVL
720
AZN
119
BDX
122
BMO
187
BMY
186
BNPQF
150
BNPQY
150
CM
121
CSCO
202
CSSE
134
DSX
131
DUK
116
ERIC
276
FE
109
FNCTF
1248
GE
151
GILD
110
GOOG
140
GOOGL
142
GSK
144
HON
254
HUBS
220
INCY
154
INTC
183
IT
381
JNJ
813
LLY
410
LTUM
142
MDT
246
MMM
156
MRK
143
MS
464
MSFT
189
NVDA
130
NVS
198
NVSEF
166
ORCL
204
PCRFF
112
PCRFY
112
PFE
201
PHG
118
PPRUF
170
PPRUY
170
REGN
144
RY
139
SAP
256
SAPGF
228
SNOW
117
SNY
904
SNYNF
744
TAK
121
TEVJF
152
TMO
267
VZ
203
Exchanges
Amex
2
Nasdaq
181
Nyse
198
Crawled Date
2024 - 04 - 11
2
2024 - 03 - 22
2
2024 - 02 - 14
2
2024 - 01 - 17
3
2024 - 01 - 16
2
2024 - 01 - 09
2
2023 - 11 - 28
2
2023 - 11 - 09
2
2023 - 11 - 03
2
2023 - 10 - 04
2
2023 - 10 - 03
4
2023 - 09 - 18
2
2023 - 09 - 11
3
2023 - 08 - 25
2
2023 - 03 - 31
2
2023 - 03 - 16
3
2023 - 02 - 20
2
2023 - 02 - 17
4
2022 - 10 - 14
2
2022 - 09 - 29
2
2022 - 09 - 19
2
2022 - 06 - 27
2
2022 - 03 - 25
4
2021 - 12 - 22
2
2021 - 12 - 20
2
2021 - 12 - 06
2
2021 - 11 - 10
1
2021 - 11 - 04
1
2021 - 11 - 01
1
2021 - 10 - 29
1
2021 - 10 - 25
1
2021 - 10 - 08
1
2021 - 09 - 22
1
2021 - 09 - 16
1
2021 - 09 - 08
1
2021 - 08 - 31
1
2021 - 08 - 27
1
2021 - 07 - 20
1
2021 - 07 - 16
1
2021 - 06 - 08
1
2021 - 06 - 03
1
2021 - 06 - 01
1
2021 - 05 - 27
1
2021 - 05 - 26
1
2021 - 05 - 25
1
2021 - 05 - 21
1
2021 - 05 - 07
1
2021 - 05 - 05
1
2021 - 05 - 04
1
2021 - 05 - 03
1
2021 - 05 - 01
1
2021 - 04 - 27
1
2021 - 04 - 12
1
2021 - 04 - 09
1
2021 - 04 - 07
1
2021 - 04 - 01
1
2021 - 03 - 29
1
2021 - 03 - 18
1
2021 - 03 - 08
1
2021 - 03 - 04
1
Crawled Time
00:00
4
00:20
1
01:00
7
02:00
5
03:00
10
04:00
2
05:00
6
06:00
18
07:00
10
08:00
8
09:00
9
10:00
3
11:00
6
12:00
11
12:15
3
12:20
5
12:30
3
13:00
9
13:30
1
14:00
6
14:20
1
15:00
7
15:15
1
15:20
3
15:30
1
16:00
7
17:00
8
18:00
8
19:00
7
20:00
5
21:00
6
22:00
8
22:01
1
23:00
8
Source
ir.voyagertherapeutics.com
1
www.biospace.com
22
www.globenewswire.com
79
www.prnewswire.com
96
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
for
symbols :
Nvs
save search
New Novartis Fabhalta® (iptacopan) data show clinically meaningful and statistically significant proteinuria reduction of 38.3% versus placebo for patients with IgA nephropathy (IgAN)
Published:
2024-04-15
(Crawled : 18:00)
- globenewswire.com
NVS
|
News
|
$98.12
3.15%
1.1M
|
Health Technology
|
0.61%
|
O:
-1.46%
H:
0.0%
C:
0.0%
fabhalta
nephropathy
for
novartis
show
Arvinas Enters into a Transaction with Novartis, including a Global License Agreement for the Development and Commercialization of PROTAC® Androgen Receptor (AR) Protein Degrader ARV-766 for the Treatment of Prostate Cancer
Published:
2024-04-11
(Crawled : 11:00)
- globenewswire.com
NVS
|
News
|
$98.12
3.15%
1.1M
|
Health Technology
|
0.22%
|
O:
0.32%
H:
0.04%
C:
-0.56%
ARVN
|
$35.24
0.97%
67K
|
Health Technology
|
-3.4%
|
O:
8.28%
H:
0.56%
C:
-4.75%
arv-766
protac
license
cancer
treatment
global
protein
for
commercialization
agreement
Novartis tender offer for MorphoSys AG commences
Published:
2024-04-11
(Crawled : 09:00)
- globenewswire.com
NVSEF
|
News
|
$95.11
490
|
Health Technology
|
1.07%
|
O:
-0.32%
H:
0.48%
C:
-0.17%
NVS
|
News
|
$98.12
3.15%
1.1M
|
Health Technology
|
0.22%
|
O:
0.32%
H:
0.04%
C:
-0.56%
MOR
|
News
|
$18.06
0.56%
35K
|
Health Technology
|
-0.14%
|
O:
0.69%
H:
0.0%
C:
-0.39%
for
novartis
LASIK Surgery Market size to record USD 1.24 bn growth from 2024-2028, Increasing medical tourism for LASIK surgery is one of the key market trends, Technavio
Published:
2024-03-28
(Crawled : 22:00)
- prnewswire.com
NVS
|
News
|
$98.12
3.15%
1.1M
|
Health Technology
|
Email alert
Add to watchlist
ABT
|
News
|
$107.565
0.46%
610K
|
Health Technology
|
Email alert
Add to watchlist
ALC
|
$81.08
0.58%
180K
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$95.11
490
|
Health Technology
|
Email alert
Add to watchlist
one
key
medical
growth
market
Novartis Fabhalta® (iptacopan) receives positive CHMP opinion as first oral monotherapy for adult patients with paroxysmal nocturnal hemoglobinuria (PNH)
Published:
2024-03-22
(Crawled : 12:00)
- globenewswire.com
NVS
|
News
|
$98.12
3.15%
1.1M
|
Health Technology
|
-1.36%
|
O:
0.17%
H:
0.28%
C:
-0.01%
fabhalta
first
chmp
positive
novartis
Global OTC Artificial Tears Analysis Report 2023-2030: The Influence of Smart Technologies, Market Positioned for Continued Expansion Amid Growing Focus on Eye Wellness
Published:
2024-03-21
(Crawled : 00:00)
- prnewswire.com
NVS
|
News
|
$98.12
3.15%
1.1M
|
Health Technology
|
-1.36%
|
O:
0.17%
H:
0.28%
C:
-0.01%
JNJ
|
News
|
$148.24
-0.59%
1.6M
|
Health Technology
|
-4.12%
|
O:
0.02%
H:
0.0%
C:
0.0%
BHC
|
$8.535
1.01%
480K
|
Health Technology
|
-11.05%
|
O:
-0.74%
H:
1.54%
C:
1.38%
ABBV
|
News
|
$169.965
1.24%
890K
|
Health Technology
|
-4.95%
|
O:
0.16%
H:
0.0%
C:
0.0%
report
expansion
global
wellness
smart
growing
eye
market
Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company's Sarcoma Franchise
Published:
2024-02-27
(Crawled : 15:30)
- biospace.com/
TSVT
|
$4.835
3.98%
96K
|
|
-15.45%
|
O:
0.0%
H:
8.64%
C:
8.36%
NVS
|
News
|
$98.12
3.15%
1.1M
|
Health Technology
|
-8.21%
|
O:
-0.15%
H:
0.31%
C:
0.06%
BLBD
|
$36.12
6.3%
85K
|
Producer Manufacturing
|
5.27%
|
O:
1.02%
H:
1.29%
C:
1.17%
ALVR
|
$0.763
7.7K
|
Health Technology
|
5.53%
|
O:
-1.42%
H:
7.9%
C:
3.52%
ADAP
|
$1.08
6.93%
160K
|
Health Technology
|
-38.41%
|
O:
3.05%
H:
5.92%
C:
1.18%
pdufa
commercial
Insulin Pen Global Market Outlook Report 2024-2028: Current Market Size and Revenue Growth Prospects for Insulin Pens, with Market Share Analysis by Type, Onset Time, End User and Geographical Region
Published:
2024-02-23
(Crawled : 17:00)
- prnewswire.com
NVSEF
|
News
|
$95.11
490
|
Health Technology
|
-7.54%
|
O:
0.37%
H:
0.58%
C:
0.58%
VTRS
|
News
A
|
$11.34
0.8%
900K
|
Health Technology
|
-15.79%
|
O:
0.0%
H:
1.93%
C:
1.27%
NVO
|
News
|
$127.41
1.72%
750K
|
Health Technology
|
0.59%
|
O:
-0.68%
H:
0.4%
C:
-0.18%
NVS
|
News
|
$98.12
3.15%
1.1M
|
Health Technology
|
-7.81%
|
O:
0.89%
H:
0.4%
C:
0.17%
JNJ
|
News
|
$148.24
-0.59%
1.6M
|
Health Technology
|
-7.06%
|
O:
0.28%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.375
0.48%
300K
|
Health Technology
|
-3.42%
|
O:
0.97%
H:
0.0%
C:
0.0%
report
revenue
global
insulin
growth
market
Erasca Announces Two Clinical Trial Collaboration and Supply Agreements for Trametinib to Evaluate Naporafenib Combination in SEACRAFT-1 and SEACRAFT-2 Trials
Published:
2024-02-14
(Crawled : 13:00)
- globenewswire.com
ERAS
|
$1.92
3.78%
120K
|
|
10.78%
|
O:
2.99%
H:
2.03%
C:
0.58%
NVS
|
News
|
$98.12
3.15%
1.1M
|
Health Technology
|
-4.33%
|
O:
-0.02%
H:
0.24%
C:
0.01%
trials
collaboration
trial
Hydroxychloroquine Market to Reach $2.86 Billion by 2028 Amidst Rising Demand for Autoimmune Disease Treatments
Published:
2024-02-13
(Crawled : 00:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-0.29%
|
O:
-2.71%
H:
0.0%
C:
0.0%
NVS
|
News
|
$98.12
3.15%
1.1M
|
Health Technology
|
-4.33%
|
O:
-0.02%
H:
0.24%
C:
0.01%
SNY
|
News
|
$47.375
0.48%
300K
|
Health Technology
|
0.23%
|
O:
-1.1%
H:
0.0%
C:
0.0%
disease
reach
market
Biologic Therapeutics Market to Increase by USD 286.12 billion during 2022-2027, North America to account for 57% of the growth - Technavio
Published:
2024-02-07
(Crawled : 08:00)
- prnewswire.com
AZNCF
|
News
|
$138.73
3.7K
|
Health Technology
|
3.65%
|
O:
-0.37%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$95.11
490
|
Health Technology
|
-7.55%
|
O:
0.41%
H:
0.0%
C:
0.0%
NVS
|
News
|
$98.12
3.15%
1.1M
|
Health Technology
|
-8.65%
|
O:
0.09%
H:
0.39%
C:
-0.36%
GSK
|
News
|
$40.995
1.0%
590K
|
Health Technology
|
-2.78%
|
O:
0.43%
H:
0.67%
C:
0.21%
BAX
|
$40.755
0.88%
450K
|
Health Technology
|
1.74%
|
O:
0.21%
H:
0.24%
C:
-1.04%
ABBV
|
News
|
$169.965
1.24%
890K
|
Health Technology
|
-1.83%
|
O:
1.48%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.375
0.48%
300K
|
Health Technology
|
-0.55%
|
O:
1.33%
H:
0.0%
C:
0.0%
BMRN
|
$91.615
2.38%
340K
|
Health Technology
|
-0.35%
|
O:
-0.38%
H:
1.79%
C:
0.22%
AZN
|
News
|
$70.54
0.59%
1.7M
|
Health Technology
|
4.61%
|
O:
-0.4%
H:
0.19%
C:
-0.33%
AMGN
|
News
|
$273.19
0.47%
360K
|
Health Technology
|
-13.97%
|
O:
-0.18%
H:
0.0%
C:
-6.22%
america
therapeutics
growth
market
Novartis to strengthen oncology pipeline with agreement to acquire MorphoSys AG for EUR 68 per share or an aggregate of EUR 2.7bn in cash
Published:
2024-02-05
(Crawled : 22:00)
- globenewswire.com
NVSEF
|
News
|
$95.11
490
|
Health Technology
|
-8.33%
|
O:
0.72%
H:
0.0%
C:
-1.56%
NVS
|
News
|
$98.12
3.15%
1.1M
|
Health Technology
|
-8.41%
|
O:
-0.15%
H:
0.6%
C:
0.42%
MOR
|
News
|
$18.06
0.56%
35K
|
Health Technology
|
4.05%
|
O:
1.39%
H:
0.34%
C:
-7.08%
pipeline
acquire
novartis
agreement
Global Sustained Release Coatings Markets, 2018-2022 and 2023-2028: Growing Demand for Controlled Drug Delivery Boosts Expansion
Published:
2024-02-01
(Crawled : 17:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
630
|
Health Technology
|
-1.2%
|
O:
-1.29%
H:
0.0%
C:
-1.38%
PFE
|
News
A
|
$26.32
0.23%
4.4M
|
Health Technology
|
-3.03%
|
O:
0.07%
H:
0.83%
C:
0.7%
NVS
|
News
|
$98.12
3.15%
1.1M
|
Health Technology
|
-8.41%
|
O:
1.55%
H:
0.79%
C:
0.25%
GSK
|
News
|
$40.995
1.0%
590K
|
Health Technology
|
2.92%
|
O:
1.27%
H:
1.87%
C:
1.73%
EMN
|
$96.8
-0.27%
78K
|
Process Industries
|
16.17%
|
O:
0.79%
H:
0.8%
C:
0.77%
drug
expansion
global
growing
Antimicrobial Therapeutics Market to grow by USD 51.4 billion from 2022 to 2027, North America accounts for 38% of market growth- Technavio
Published:
2024-01-17
(Crawled : 06:00)
- prnewswire.com
CSLLY
|
$89.17
54K
|
n/a
|
-4.78%
|
O:
-0.64%
H:
0.54%
C:
0.54%
GLAXF
|
News
|
$20.305
630
|
Health Technology
|
3.62%
|
O:
-0.56%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-10.78%
|
O:
-1.83%
H:
0.0%
C:
0.0%
ALPMY
|
News
|
$9.53
690K
|
Manufacturing
|
-21.24%
|
O:
-1.74%
H:
0.0%
C:
-1.35%
NVS
|
News
|
$98.12
3.15%
1.1M
|
Health Technology
|
-12.0%
|
O:
0.49%
H:
0.18%
C:
0.04%
GSK
|
News
|
$40.995
1.0%
590K
|
Health Technology
|
1.78%
|
O:
-0.08%
H:
0.1%
C:
-0.18%
ABBV
|
News
|
$169.965
1.24%
890K
|
Health Technology
|
3.64%
|
O:
-0.15%
H:
0.74%
C:
0.18%
SNY
|
News
|
$47.375
0.48%
300K
|
Health Technology
|
-10.44%
|
O:
0.45%
H:
0.06%
C:
-0.5%
america
therapeutics
market
Osteoarthritis Therapeutics Market to grow by USD 3.96 billion from 2022-2027, North America to account for 32% of market growth - Technavio
Published:
2024-01-17
(Crawled : 05:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
630
|
Health Technology
|
3.62%
|
O:
-0.56%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-10.78%
|
O:
-1.83%
H:
0.0%
C:
0.0%
VTRS
|
News
A
|
$11.34
0.8%
900K
|
Health Technology
|
-4.26%
|
O:
-1.02%
H:
0.95%
C:
-1.46%
NVS
|
News
|
$98.12
3.15%
1.1M
|
Health Technology
|
-12.0%
|
O:
0.49%
H:
0.18%
C:
0.04%
GSK
|
News
|
$40.995
1.0%
590K
|
Health Technology
|
1.78%
|
O:
-0.08%
H:
0.1%
C:
-0.18%
ABT
|
News
|
$107.565
0.46%
610K
|
Health Technology
|
-5.65%
|
O:
0.12%
H:
0.77%
C:
0.27%
SNY
|
News
|
$47.375
0.48%
300K
|
Health Technology
|
-10.44%
|
O:
0.45%
H:
0.06%
C:
-0.5%
ANIK
|
$25.92
-0.12%
5.2K
|
Health Technology
|
18.22%
|
O:
-1.05%
H:
3.55%
C:
3.31%
america
osteoarthritis
therapeutics
growth
market
Global Pseudomonas Aeruginosa Infection Treatment Market Report 2024-2034: Rising Antibiotic Resistance Drives Demand for Pseudomonas Aeruginosa Infection Treatments
Published:
2024-01-17
(Crawled : 02:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
630
|
Health Technology
|
3.62%
|
O:
-0.56%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-10.78%
|
O:
-1.83%
H:
0.0%
C:
0.0%
NVS
|
News
|
$98.12
3.15%
1.1M
|
Health Technology
|
-12.0%
|
O:
0.49%
H:
0.18%
C:
0.04%
JNJ
|
News
|
$148.24
-0.59%
1.6M
|
Health Technology
|
-7.91%
|
O:
-1.02%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.995
1.0%
590K
|
Health Technology
|
1.78%
|
O:
-0.08%
H:
0.1%
C:
-0.18%
ABT
|
News
|
$107.565
0.46%
610K
|
Health Technology
|
-5.65%
|
O:
0.12%
H:
0.77%
C:
0.27%
SNY
|
News
|
$47.375
0.48%
300K
|
Health Technology
|
-10.44%
|
O:
0.45%
H:
0.06%
C:
-0.5%
GILD
|
$67.36
0.61%
1.2M
|
Health Technology
|
-22.14%
|
O:
-0.19%
H:
0.87%
C:
0.76%
report
infection
treatment
global
market
Electron Microscope Market size to grow by USD 1.68 billion from 2022 to 2027; APAC to account for 55% of market growth- Technavio
Published:
2024-01-16
(Crawled : 09:00)
- prnewswire.com
ATEYY
|
$34.01
3.1M
|
n/a
|
-2.33%
|
O:
1.01%
H:
2.93%
C:
2.47%
NINOY
|
$9.88
1.4K
|
Manufacturing
|
-2.37%
|
O:
-0.2%
H:
0.0%
C:
-0.99%
TMO
|
News
|
$572.645
4.43%
800K
|
Health Technology
|
-0.09%
|
O:
-0.89%
H:
0.0%
C:
0.0%
NVS
|
News
|
$98.12
3.15%
1.1M
|
Health Technology
|
-11.8%
|
O:
0.16%
H:
0.43%
C:
0.07%
KEYS
|
$146.74
1.38%
200K
|
Electronic Technology
|
-4.74%
|
O:
-0.78%
H:
0.42%
C:
-0.04%
market
Allergy Immunotherapies Market to grow by USD 1.01 billion from 2022 to 2027; Europe to account for 53% of market growth - Technavio
Published:
2024-01-16
(Crawled : 03:00)
- prnewswire.com
VTRS
|
News
A
|
$11.34
0.8%
900K
|
Health Technology
|
-3.68%
|
O:
-0.6%
H:
1.34%
C:
1.21%
NVS
|
News
|
$98.12
3.15%
1.1M
|
Health Technology
|
-11.8%
|
O:
0.16%
H:
0.43%
C:
0.07%
europe
growth
market
Lantheus Announces Acceptance of its First-to-File ANDA for Generic LUTATHERA® (Lutetium Lu 177 Dotatate)
Published:
2024-01-11
(Crawled : 13:00)
- globenewswire.com
NVS
|
News
|
$98.12
3.15%
1.1M
|
Health Technology
|
-11.79%
|
O:
-0.22%
H:
0.43%
C:
0.37%
LNTH
|
$64.01
1.49%
52K
|
Health Technology
|
6.38%
|
O:
0.32%
H:
0.03%
C:
-4.42%
lutathera
Castration-Resistant Prostate Cancer (CRPC) Treatment Market size to grow by USD 5.98 billion from 2023 to 2028, North America to account for 47% of market growth- Technavio
Published:
2024-01-09
(Crawled : 03:00)
- prnewswire.com
ALPMF
|
News
|
$9.75
200
|
Health Technology
|
-21.12%
|
O:
0.16%
H:
0.0%
C:
-3.88%
NVSEF
|
News
|
$95.11
490
|
Health Technology
|
-10.48%
|
O:
-0.24%
H:
0.0%
C:
0.0%
ALPMY
|
News
|
$9.53
690K
|
Manufacturing
|
-22.39%
|
O:
-1.22%
H:
0.0%
C:
-0.72%
NVS
|
News
|
$98.12
3.15%
1.1M
|
Health Technology
|
-11.5%
|
O:
-0.46%
H:
0.74%
C:
-0.19%
SNY
|
News
|
$47.375
0.48%
300K
|
Health Technology
|
-10.2%
|
O:
0.74%
H:
0.0%
C:
0.0%
AMGN
|
News
|
$273.19
0.47%
360K
|
Health Technology
|
-12.54%
|
O:
-0.92%
H:
0.63%
C:
-0.25%
america
cancer
treatment
market
← Previous
1
2
3
4
5
6
7
8
9
10
Next →
Gainers vs Losers
89%
11%
Top 10 Gainers
MTTR
|
News
M
|
$4.65
167.24%
9.8M
|
AGBA
|
$2.355
88.4%
34M
|
Finance
EDBL
|
News
|
$6.75
79.52%
1.5M
|
CZOO
|
$8.77
75.75%
11M
|
VNRX
|
$0.84
40.0%
2.6M
|
Health Technology
OPRT
|
News
|
$3.01
33.78%
6.8M
|
Finance
MLEC
|
$1.81
29.29%
2M
|
n/a
CMAX
|
$4.12
28.35%
65K
|
Manufacturing
MTC
|
$2.0
28.21%
1.7M
|
Technology Services
PEGY
|
$0.0586
27.95%
130M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.